Streptokinase for malignant pleural effusions: A randomized controlled study

Asian Cardiovascular and Thoracic Annals

Volumn 19, Issue 3-4, 2011, Pages 238-243

  Okur, Erdal ^a   Baysungur, Volkan ^b   Tezel, Cagatay ^b   Ergene, Gokhan ^b   Okur, Hacer Kuzu ^b   Halezeroglu, Semih ^a  

^a ACIBADEM UNIVERSITY   (Turkey)

^b Sureyyapasa Chest Diseases and Thoracic Surgery Teaching Hospital   (Turkey)

Author keywords

Fibrinolytic agents; Lung neoplasms; Malignant; Pleural effusion; Pleurodesis; Streptokinase

Indexed keywords

STREPTOKINASE; TALC;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; FEMALE; FIBRINOLYSIS; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; PLEURA EFFUSION; PLEURODESIS; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 80054784351     PISSN: 02184923     EISSN: 18165370     Source Type: Journal    
DOI: 10.1177/0218492311410874     Document Type: Article

References (14)

1. Antunes G, Neville E, Duffy J and Ali N. Pleural Diseases Group, Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 8(Suppl 2): 29-38.
2. Qureshi RA, Collinson SL, Powell RJ, Froeschle PO and Berrisford RG. Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann 2008; 16: 120-123. (Pubitemid 351649798)
3. Maskell NA and Gleeson FV. Images in clinical medicine. Effect of intrapleural streptokinase on a loculated malignant effusion. N Eng J Med 2003; 348: e4.
4. Tokuda Y, Matsushima D, Stein GH and Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions a meta-analysis. Chest 2006; 129: 783-790.
5. Cameron R and Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2008; 2: CD002312.
6. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J and Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999; 159: 37-42. (Pubitemid 29036500)
7. Davies RJ, Traill ZC and Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-421.
8. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW and Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170: 49-53. (Pubitemid 38997750)
9. Davies CW, Traill ZC, Gleeson FV and Davies RJ. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999; 115: 729-733. (Pubitemid 29129953)
10. Gilkeson RC, Silverman P and Haaga JR. Using urokinase to treat malignant pleural effusions. AJR Am J Roentgenol 1999; 173: 781-783. (Pubitemid 29395311)
11. Hsu LH, Soong TC, Feng AC and Liu MC. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J Thorac Oncol 2006; 1: 460-467. (Pubitemid 47181424)
12. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials explanation and elaboration. Ann Intern Med 2001; 134: 663-694. (Pubitemid 32322245)
13. Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G and Faurschou P. Treatment of malignant pleural effusion pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998; 92: 593-596. (Pubitemid 28162178)
14. Seaton KG, Patz Jr EF and Goodman PC. Palliative treatment of malignant pleural effusions value of smallbore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol 1995; 164: 589-591.